References
- Bedawi EO, Hassan M, Rahman NM. Recent developments in the management of pleural infection: a comprehensive review. Clin Respir J. 2018;12:2309–2320.
- Grijalva CG, Zhu Y, Nuorti JP, et al. Emergence of parapneumonic empyema in the USA. Thorax. 2011;66:663–668.
- Søgaard M, Nielsen RB, Nørgaard M, et al. Incidence, length of stay, and prognosis of hospitalized patients with Pleural Empyema. Chest. 2014;145:189–192.
- Finley C, Clifton J, Fitzgerald JM, et al. Empyema: an increasing concern in Canada. Can Respir J. 2008;15:85–89.
- Shen H-N, Lu C-L, Li C-Y. Epidemiology of pleural infections in Taiwan from 1997 through 2008: pleural infections in Taiwan. Respirology. 2012;17:1086–1093.
- Corcoran JP, Wrightson JM, Belcher E, et al. Pleural infection: past, present, and future directions. Lancet Respir Med. 2015;3:563–577.
- Weinberger DM, Harboe ZB, Viboud C, et al. Pneumococcal disease seasonality: incidence, severity and the role of influenza activity. Eur Respir J. 2014;43:833–841.
- Bender JM, Ampofo K, Sheng X, et al. Parapneumonic Empyema deaths during past century, Utah. Emerg Infect Dis. 2009;15:44–48.
- Hassan M, Cargill T, Harriss E, et al. The microbiology of pleural infection in adults: a systematic review. Eur Respir J. 2019;54:1900542.
- Richet H. Seasonality in Gram-negative and healthcare-associated infections. Clin Microbiol Infect. 2012;18:934–940.
- Davies HE, Davies RJO, Davies CWH, on behalf of the BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65:ii41–ii53.
- Rahman NM, Maskell NA, West A, et al. at al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518–526.
- Marks DJB, Fisk MD, Koo CY, et al. Thoracic Empyema: A 12-year study from a UK tertiary cardiothoracic referral centre. Wilkinson RJ, editor. PLoS ONE. 2012;7:e30074.
- Maskell NA, Davies CWH, Nunn AJ, et al. U.K. Controlled trial of intrapleural streptokinase for Pleural Infection. N Engl J Med. 2005;352:865–874.
- Evison M, Blyth KG, Bhatnagar R, et al. Providing safe and effective pleural medicine services in the UK: an aspirational statement from UK pleural physicians. BMJ Open Respir Res. 2018;5:e000307.
- Arnold D, Hamilton F, Morris T, et al. S12 The changes in incidence and management of pleural empyema in England over the last decade. In: British Thoracic Society Winter Meeting; 2019 Dec 4-6; London. London: BMJ Publishing Group Ltd and British Thoracic Society; 2019. Abstract no S12.
- Davies CW, Kearney SE, Gleeson FV, et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160:1682–1687.
- Boyanova L, Djambazov V, Gergova G, et al. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study. Anaerobe. 2004;10:261–267.
- Dyrhovden R, Nygaard RM, Patel R, et al. The bacterial aetiology of pleural empyema. A descriptive and comparative metagenomic study. Clin Microbiol Infect. 2019;25:981–986.
- Lisboa T, Waterer GW, Lee YCG. Pleural infection: changing bacteriology and its implications: pleural infection: changing bacteriology. Respirology. 2011;16:598–603.